Cargando…

Point of Care Tests VerifyNow P2Y12 and INNOVANCE PFA P2Y Compared to Light Transmittance Aggregometry After Fibrinolysis

Detection of high on-treatment platelet reactivity (HPR) by point-of-care tests has not been validated after successful fibrinolysis for ST-elevation myocardial infarction. We assessed the validity of the point-of-care VerifyNow P2Y12 (VN) and INNOVANCE PFA P2Y (PFA) tests on HPR compared to light t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roule, Vincent, Ardouin, Pierre, Repessé, Yohan, Le Querrec, Agnès, Blanchart, Katrien, Lemaitre, Adrien, Sabatier, Rémi, Borel-Derlon, Annie, Beygui, Farzin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714754/ https://www.ncbi.nlm.nih.gov/pubmed/29719963 http://dx.doi.org/10.1177/1076029618772354

Ejemplares similares

Prehospital fibrinolysis versus primary percutaneous coronary intervention in ST-elevation myocardial infarction: a systematic review and meta-analysis of randomized controlled trials
por: Roule, Vincent, et al.
Publicado: (2016)

Glycoprotein IIb/IIIa inhibitors use in the setting of primary percutaneous coronary intervention for ST elevation myocardial infarction in patients pre‐treated with newer P2Y12 inhibitors
por: Blanchart, Katrien, et al.
Publicado: (2021)

Multiple Interventional Procedures as an Alternative to Cardiac Transplantation
por: Blanchart, Katrien, et al.
Publicado: (2019)

Evaluation of Left Main Coronary Artery Using Optical Frequency Domain Imaging and Its Pitfalls
por: Roule, Vincent, et al.
Publicado: (2020)

Systematic review and meta-analysis of the prognostic impact of cancer among patients with acute coronary syndrome and/or percutaneous coronary intervention
por: Roule, Vincent, et al.
Publicado: (2020)

Occluded or Not?: A Subtle Electrocardiographic Answer
por: Plane, Anne-Flore, et al.
Publicado: (2019)

Different Influences of Hematocrit on the Results of Two Point-Of-Care Platelet Function Tests, the VerifyNow Assay and Multiple Electrode Platelet Aggregometry
por: Kim, Yun Gi, et al.
Publicado: (2014)

Vitamin K antagonist vs direct oral anticoagulants with antiplatelet therapy in dual or triple therapy after percutaneous coronary intervention or acute coronary syndrome in atrial fibrillation: Meta‐analysis of randomized controlled trials
por: Roule, Vincent, et al.
Publicado: (2019)

Investigation of the interaction between proton pump inhibitors and clopidogrel using VerifyNow P2Y12 assay
por: Lin, Sheng-Feng, et al.
Publicado: (2020)

Impact of wait times on late postprocedural mortality after successful transcatheter aortic valve replacement
por: Roule, Vincent, et al.
Publicado: (2022)

Effects of Vonoprazan on the Antiplatelet Function of Prasugrel Assessed by the VerifyNow P2Y(12) Assay in Patients With Coronary Artery Disease
por: Koga, Seiji, et al.
Publicado: (2020)

Comparison of Light Transmission Aggregometry With Impedance Aggregometry in Patients on Potent P2Y12 Inhibitors
por: Wadowski, Patricia P., et al.
Publicado: (2020)

The optimal threshold of high post-treatment platelet reactivity could be defined by a point-of-care VerifyNow P2Y12 assay
por: Jeong, Young-Hoon, et al.
Publicado: (2008)

Periprocedural Variability of Platelet Functions in Carotid Artery Stenting: An Analysis Using VerifyNow
por: Yoshimura, Masataka, et al.
Publicado: (2021)

Comparison of VerifyNow, thromboelastography, and PL-12 in patients with minor ischemic stroke or transient ischemic attack
por: Ma, Lin, et al.
Publicado: (2021)

Clopidogrel non-responsiveness in patients undergoing percutaneous coronary intervention using the VerifyNow test: frequency and predictors
por: Yaseen, Israa Fadhil, et al.
Publicado: (2019)

Impact of Routine Platelet Reactivity Testing with VerifyNow Assay on Antiplatelet Choice After Percutaneous Coronary Intervention
por: Mshelbwala, Fakilahyel S, et al.
Publicado: (2020)

Blood loss after coronary artery bypass by aspirin responsiveness assessed with preoperative VerifyNow aspirin testing
por: Willemsen, Laura M., et al.
Publicado: (2021)

Use of the VerifyNow point of care assay to assess the pharmacodynamic effects of loading and maintenance dose regimens of prasugrel and ticagrelor
por: Angiolillo, Dominick J., et al.
Publicado: (2021)

Performance comparison of aspirin assay between Anysis and VerifyNow: Assessment of therapeutic platelet inhibition in patients with cardiac diseases
por: Piao, Jinxiang, et al.
Publicado: (2021)

Comparison of VerifyNow-P2Y(12 )test and Flow Cytometry for monitoring individual platelet response to clopidogrel. What is the cut-off value for identifying patients who are low responders to clopidogrel therapy?
por: Godino, Cosmo, et al.
Publicado: (2009)

Comparing of Light Transmittance Aggregometry and Modified Thrombelastograph in Predicting Clinical Outcomes in Chinese Patients Undergoing Coronary Stenting with Clopidogrel
por: Tang, Xiao-Fang, et al.
Publicado: (2015)

Change of Platelet Reactivity to Antiplatelet Therapy after Stenting Procedure for Cerebral Artery Stenosis: VerifyNow Antiplatelet Assay before and after Stenting
por: Lee, Deok Hee, et al.
Publicado: (2012)

Application of Auxiliary VerifyNow Point-of-Care Assays to Assess the Pharmacodynamics of RUC-4, a Novel αIIbβ3 Receptor Antagonist
por: Bentur, Ohad S., et al.
Publicado: (2021)

Verifynow P2Y(12) PRU-Guided Modification of Clopidogrel for Prevention of Recurrent Ischemic Stroke: A Real-World Prospective Cohort Study
por: Zhang, Yuanjin, et al.
Publicado: (2022)

Selective and rapid monitoring of dual platelet inhibition by aspirin and P2Y(12 )antagonists by using multiple electrode aggregometry
por: Penz, Sandra M, et al.
Publicado: (2010)

The vacuolar DHHC-CRD protein Pfa3p is a protein acyltransferase for Vac8p
por: Smotrys, Jessica E., et al.
Publicado: (2005)

96-well plate-based aggregometry
por: Chan, Melissa V., et al.
Publicado: (2018)

SOFTWARE DESIGN FOR PFA TOOLS
por: Thomson, M.
Publicado: (2012)

Identification of High Platelet Reactivity Despite ADP P2Y (12) Inhibitor Treatment: Two Populations in the Vasodilator-Stimulated Phosphoprotein Assay and Variable PFA-P2Y Shapes of Curve
por: Mariethoz, Cyril, et al.
Publicado: (2023)

Reduction of Preoperative Waiting Time Before Urgent Surgery for Patients on P2Y(12) Inhibitors Using Multiple Electrode Aggregometry: A Retrospective Study
por: Hardy, Michaël, et al.
Publicado: (2020)

First validation of myocardial flow reserve assessed by dynamic (99m)Tc-sestamibi CZT-SPECT camera: head to head comparison with (15)O-water PET and fractional flow reserve in patients with suspected coronary artery disease. The WATERDAY study
por: Agostini, Denis, et al.
Publicado: (2018)

Whole blood impedance aggregometry findings in experimental endotoxinemia
por: Simm, Vivian, et al.
Publicado: (2013)

PLATELET AGGREGOMETRY INTERPRETATION USING ROTEM – PART – II
por: Bhardwaj, Vandana, et al.
Publicado: (2016)

Facilitation of transmitter release from rat sympathetic neurons via presynaptic P2Y(1 )receptors
por: Chandaka, Giri K, et al.
Publicado: (2008)

Facilitation of transmitter release from rat sympathetic neurons via presynaptic P2Y(1) receptors
por: Chandaka, Giri K, et al.
Publicado: (2011)

Application of PFA tools to sLHC detectors
por: Ruan, M.
Publicado: (2015)

Tissue sparing surgery in knee reconstruction: unicompartmental (UKA), patellofemoral (PFA), UKA + PFA, bi-unicompartmental (Bi-UKA) arthroplasties
por: Confalonieri, N., et al.
Publicado: (2008)

The Significance of Clopidogrel Low-Responsiveness on Stent Thrombosis and Cardiac Death Assessed by the Verifynow P(2)Y(12) Assay in Patients With Acute Coronary Syndrome Within 6 Months After Drug-Eluting Stent Implantation
por: Lee, Kyounghoon, et al.
Publicado: (2009)

Influence of the sample anticoagulant on the measurements of impedance aggregometry in cardiac surgery
por: Solomon, Cristina, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_qdtq40vb2uojgp1pn91illorlo